{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T11:52:26Z","timestamp":1723636346812},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The main objective of this study was to evaluate the cumulative incidence of cause-specific mortality and other causes of mortality for patients with olfactory neuroblastoma (ONB). The secondary aim was to model the probability of cause-specific death and build a competing risk nomogram to predict cause-specific mortality for this disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients with ONB from 1975 to 2016 were identified from the Surveillance, Epidemiology, and End Results database. We estimated the cumulative incidence function (CIF) for cause-specific mortality and other causes of mortality, and constructed the Fine and Gray\u2019s proportional subdistribution hazard model, as well as a competing-risk nomogram based on Fine and Gray\u2019s model, to predict the probability of cause-specific mortality for patients with ONB.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After data selection, 826 cases were included for analysis. Five-year cumulative incidence of cause-specific mortality was 19.5% and cumulative incidence of other causes of mortality was 11.3%. Predictors of cause-specific mortality for ONB included tumor stage, surgery and chemotherapy. Age was most strongly predictive of other causes of mortality: patients aged\u2009&gt;\u200960 years exhibited subdistribution hazard ratios of 1.063 (95\u2009% confidence interval [CI] 1.05\u20131.08; <jats:italic>p<\/jats:italic>\u2009=\u20090.001). The competing risk nomogram for cause-specific mortality was well-calibrated, and had good discriminative ability (concordance index\u2009=\u20090.79).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We calculated the CIF of cause-specific mortality and other causes of mortality in patients with the rare malignancy ONB. We also built the first competing risk nomogram to provide useful individualized predictive information for patients with ONB.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-021-01784-8","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T10:03:23Z","timestamp":1623319403000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Model to predict cause\u2010specific mortality in patients with olfactory neuroblastoma: a competing risk analysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Lipin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuzi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dazhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonggang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"issue":"4a","key":"1784_CR1","first-page":"2683","volume":"17","author":"G Broich","year":"1997","unstructured":"Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res. 1997;17(4a):2683\u2013706.","journal-title":"Anticancer Res"},{"issue":"11","key":"1784_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1470-2045(01)00558-7","volume":"2","author":"P Dulguerov","year":"2001","unstructured":"Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001;2(11):683\u201390.","journal-title":"Lancet Oncol"},{"issue":"3","key":"1784_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/archotol.133.3.276","volume":"133","author":"D Jethanamest","year":"2007","unstructured":"Jethanamest D, Morris LG, Sikora AG, Kutler DI. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg. 2007;133(3):276\u201380.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"1784_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1748-717X-6-41","volume":"6","author":"ME Platek","year":"2011","unstructured":"Platek ME, Merzianu M, Mashtare TL, Popat SR, Rigual NR, Warren GW, Singh AK. Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol (Lond England). 2011;6:41.","journal-title":"Radiat Oncol (Lond England)"},{"key":"1784_CR5","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2147\/CMAR.S151945","volume":"10","author":"Z Yin","year":"2018","unstructured":"Yin Z, Wang Y, Wu Y, Zhang X, Wang F, Wang P, Tao Z, Yuan Z. Age distribution and age-related outcomes of olfactory neuroblastoma: a population-based analysis. Cancer Manag Res. 2018;10:1359\u201364.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"1784_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00005537-200301000-00029","volume":"113","author":"A Argiris","year":"2003","unstructured":"Argiris A, Dutra J, Tseke P, Haines K. Esthesioneuroblastoma: the Northwestern University experience. Laryngoscope. 2003;113(1):155\u201360.","journal-title":"Laryngoscope"},{"issue":"7","key":"1784_CR7","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/lary.25862","volume":"126","author":"VE Banuchi","year":"2016","unstructured":"Banuchi VE, Dooley L, Lee NY, Pfister DG, McBride S, Riaz N, Bilsky MH, Ganly I, Shah JP, Kraus DH, et al. Patterns of regional and distant metastasis in esthesioneuroblastoma. Laryngoscope. 2016;126(7):1556\u201361.","journal-title":"Laryngoscope"},{"issue":"2","key":"1784_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ijrobp.2009.10.067","volume":"79","author":"OK Noh","year":"2011","unstructured":"Noh OK, Lee SW, Yoon SM, Kim SB, Kim SY, Kim CJ, Jo KJ, Choi EK, Song SY, Kim JH, et al. Radiotherapy for esthesioneuroblastoma: is elective nodal irradiation warranted in the multimodality treatment approach? Int J Radiat Oncol Biol Phys. 2011;79(2):443\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1784_CR9","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/hed.23327","volume":"36","author":"TJ Ow","year":"2014","unstructured":"Ow TJ, Hanna EY, Roberts DB, Levine NB, El-Naggar AK, Rosenthal DI, DeMonte F, Kupferman ME. Optimization of long-term outcomes for patients with esthesioneuroblastoma. Head Neck. 2014;36(4):524\u201330.","journal-title":"Head Neck"},{"issue":"6","key":"1784_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/1097-0347(200009)22:6<550::AID-HED2>3.0.CO;2-0","volume":"22","author":"VA Resto","year":"2000","unstructured":"Resto VA, Eisele DW, Forastiere A, Zahurak M, Lee DJ, Westra WH. Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck. 2000;22(6):550\u20138.","journal-title":"Head Neck"},{"issue":"7","key":"1784_CR11","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/lary.20280","volume":"119","author":"AK Devaiah","year":"2009","unstructured":"Devaiah AK, Andreoli MT. Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients. Laryngoscope. 2009;119(7):1412\u20136.","journal-title":"Laryngoscope"},{"issue":"2","key":"1784_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3171\/2010.2.JNS091897","volume":"113","author":"AJ Kane","year":"2010","unstructured":"Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, Buencamino R, Fang S, Barani IJ, Parsa AT. Posttreatment prognosis of patients with esthesioneuroblastoma. J Neurosurg. 2010;113(2):340\u201351.","journal-title":"J Neurosurg"},{"issue":"4","key":"1784_CR13","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.ijrobp.2009.09.019","volume":"78","author":"M Ozsahin","year":"2010","unstructured":"Ozsahin M, Gruber G, Olszyk O, Karakoyun-Celik O, Pehlivan B, Azria D, Roelandts M, Kaanders JH, Cengiz M, Krengli M, et al. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study. Int J Radiat Oncol Biol Phys. 2010;78(4):992\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1784_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1055\/s-0037-1607298","volume":"79","author":"RSR Woods","year":"2018","unstructured":"Woods RSR, Subramaniam T, Leader M, McConn-Walsh R, O\u2019Neill JP, Lacy PD. Changing trends in the management of Esthesioneuroblastoma: irish and international perspectives. J Neurol Surg Part B Skull Base. 2018;79(3):262\u20138.","journal-title":"J Neurol Surg Part B Skull Base"},{"issue":"11","key":"1784_CR15","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1200\/JCO.2015.65.0739","volume":"34","author":"R Carmona","year":"2016","unstructured":"Carmona R, Zakeri K, Green G, Hwang L, Gulaya S, Xu B, Verma R, Williamson CW, Triplett DP, Rose BS, et al. Improved method to stratify elderly patients with cancer at risk for competing events. J Clin Oncol. 2016;34(11):1270\u20137.","journal-title":"J Clin Oncol"},{"issue":"31","key":"1784_CR16","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1200\/JCO.2006.08.0499","volume":"25","author":"EO Hanrahan","year":"2007","unstructured":"Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, Rouzier R, Broglio KR, Hortobagyi GN, Valero V. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. J Clin Oncol. 2007;25(31):4952\u201360.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1784_CR17","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1200\/JCO.2012.42.4457","volume":"31","author":"L Yang","year":"2013","unstructured":"Yang L, Shen W, Sakamoto N. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer. J Clin Oncol. 2013;31(4):468\u201374.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1784_CR18","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.eururo.2014.09.019","volume":"67","author":"JA Brockman","year":"2015","unstructured":"Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco FJ Jr, Rabah DM, Klein EA, et al. Nomogram predicting prostate cancer-specific mortality for men with biochemical recurrence after radical prostatectomy. Eur Urol. 2015;67(6):1160\u20137.","journal-title":"Eur Urol"},{"key":"1784_CR19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141\u201354.","journal-title":"Ann Stat"},{"key":"1784_CR20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of competing risks in survival analysis. J Am Stat Assoc. 1999;94:496\u2013509.","journal-title":"J Am Stat Assoc"},{"issue":"20","key":"1784_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.21037\/atm.2017.07.27","volume":"5","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Geskus RB, Kattan MW, Zhang H, Liu T. Nomogram for survival analysis in the presence of competing risks. Ann Transl Med. 2017;5(20):403.","journal-title":"Ann Transl Med"},{"issue":"5","key":"1784_CR22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1227\/00006123-199305000-00002","volume":"32","author":"A Morita","year":"1993","unstructured":"Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery. 1993;32(5):706\u201314 discussion 714\u2013705.","journal-title":"Neurosurgery"},{"issue":"3","key":"1784_CR23","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L","volume":"37","author":"S Kadish","year":"1976","unstructured":"Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer. 1976;37(3):1571\u20136.","journal-title":"Cancer"},{"key":"1784_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2407-12-117","volume":"12","author":"G Bisogno","year":"2012","unstructured":"Bisogno G, Soloni P, Conte M, Podda M, Ferrari A, Garaventa A, Luksch R, Cecchetto G. Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees. BMC Cancer. 2012;12:117.","journal-title":"BMC Cancer"},{"key":"1784_CR25","doi-asserted-by":"crossref","unstructured":"Eich HT, M\u00fcller RP, Micke O, Kocher M, Berthold F, Hero B. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment? Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al]. 2005;181(6):378\u201384.","DOI":"10.1007\/s00066-005-1362-2"},{"issue":"5","key":"1784_CR26","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/neuros\/nyx535","volume":"83","author":"A Orton","year":"2018","unstructured":"Orton A, Boothe D, Evans D, Lloyd S, Monroe MM, Jensen R, Shrieve DC, Hitchcock YJ. Esthesioneuroblastoma: a patterns-of-care and outcomes analysis of the national cancer database. Neurosurgery. 2018;83(5):940\u20137.","journal-title":"Neurosurgery"},{"issue":"3","key":"1784_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/COC.0000000000000649","volume":"43","author":"LD Cranmer","year":"2020","unstructured":"Cranmer LD, Chau B, Rockhill JK, Ferreira M Jr, Liao JJ. Chemotherapy in esthesioneuroblastoma\/olfactory neuroblastoma: an analysis of the surveillance epidemiology and end results (SEER) 1973\u20132015 database. Am J Clin Oncol. 2020;43(3):203\u20139.","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"1784_CR28","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/1097-0142(197909)44:3<1087::AID-CNCR2820440343>3.0.CO;2-A","volume":"44","author":"D Elkon","year":"1979","unstructured":"Elkon D, Hightower SI, Lim ML, Cantrell RW, Constable WC. Esthesioneuroblastoma. Cancer. 1979;44(3):1087\u201394.","journal-title":"Cancer"},{"key":"1784_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.oraloncology.2015.11.021","volume":"53","author":"ZZ Yin","year":"2016","unstructured":"Yin ZZ, Gao L, Luo JW, Yi JL, Huang XD, Qu Y, Wang K, Zhang SP, Xiao JP, Xu GZ, et al. Long-term outcomes of patients with esthesioneuroblastomas: A cohort from a single institution. Oral Oncol. 2016;53:48\u201353.","journal-title":"Oral Oncol"},{"issue":"5","key":"1784_CR30","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/00006123-199805000-00045","volume":"42","author":"RS Polin","year":"1998","unstructured":"Polin RS, Sheehan JP, Chenelle AG, Munoz E, Larner J, Phillips CD, Cantrell RW, Laws ER Jr, Newman SA, Levine PA, et al. The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience. Neurosurgery. 1998;42(5):1029\u201337.","journal-title":"Neurosurgery"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01784-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-021-01784-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01784-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T10:04:30Z","timestamp":1623319470000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-021-01784-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1784"],"URL":"https:\/\/doi.org\/10.1186\/s13014-021-01784-8","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"assertion":[{"value":"14 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}